potential indications for glp-1 receptor agonists keep expanding Exploring glucagon-like peptide-1 as disease-modifying agent in psychiatric and neurodevelopmental conditions: evidence from a drug target Mendelian randomization | BMC Psychiatry Could GLP-1 Receptor Agonists Help

Results showed that while BPC-157 excelled at localized tissue repair with 63% of participants achieving complete healing within 4 weeks, TB-500 demonstrated superior systemic benefits with 71% of subjects reporting improved overall recovery and performance metrics

Tirzepatide and retatrutide (single molecule): A single engineered molecule that hits multiple receptors simplifies the formulation to one compound with one pharmacokinetic profile, and allows the balance of receptor activation to be tuned at the molecular-design level

Pharmacol Biochem Behav 99:211216

This cyclical relationship between HPA axis dysregulation and neuroinflammation highlights the complexity of the biological mechanisms underlying depression

Mechanism disclosure : does the product tell you which ingredient supports which biological target (oxidative-stress defence, mitochondrial ATP, one-carbon metabolism)